Article
Glycosylation is a novel TGFβ1-independent post-translational modification of Smad2.
Biochemical and biophysical research communications - 22 Jan 2020
Gotoh Takaya, Iwahana Hiroyuki, Kannan Surya, Marei Reham Ghazal, Mousa Hanaa, Elgamal Mahmoud, Souchelnytskyi Serhiy
Abstract excerpt
Smad2 is a crucial component of intracellular signaling by transforming growth factor-β (TGFβ). Here we describe that Smad2 is glycosylated, which is a novel for Smad2 post-translational modification. We showed that the Smad2 glycosylation was inhibited upon treatment of cells with 17β-estradiol, and was enhanced in cells in a dense culture as compared to cells in a sparse culture. The Smad2 glycosylation was not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
